Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

7.53
Delayed Data
As of 3:59pm ET
 -0.22 / -2.84%
Today’s Change
5.06
Today|||52-Week Range
11.74
+7.57%
Year-to-Date

Today’s Trading

Previous close7.75
Today’s open8.12
Day’s range7.42 - 8.24
Volume1,871,444
Average volume (3 months)960,342
Market cap$121.6M
Dividend yield--
Data as of 3:59pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)-128.57%
Earnings growth (this year)-6.02%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
DPRXDipexium Pharmaceuti...-0.04-0.28%
ANTHAnthera Pharmaceutic...+0.21+4.86%
AXNAoxing Pharmaceutica...-0.12-6.53%
--Ecogreen Fine Chemic...-0.00-0.83%
Data as of 4:05pm ET, 03/30/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$0.00
Annual profit (last year)-$22.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account